发明名称 siRNA molecules for the treatment of blood vessels
摘要 The present invention relates to a nucleic acid molecule, a genetic construct, siRNA molecules and a composition which comprises the nucleic acid molecule and/or the genetic construct and/or the siRNA molecules and can be used for inhibition of the expression of endothelial adhesion molecules. The invention also relates to a device, which is coated with the aforementioned molecules, the composition or the construct, or contains them. The present invention further relates to a corresponding use of the nucleic acid molecule, of the genetic construct or of the siRNA molecules and a method of inhibition of the expression of adhesion molecules and a method of vessel grafting, lung transplantation, treatment of lung transplants, and a method of treatment of the open heart within the scope of cardioplegia.
申请公布号 US9127281(B2) 申请公布日期 2015.09.08
申请号 US200611814213 申请日期 2006.01.19
申请人 Eberhard-Karls-Universität Tübingen Universitätsklinikum 发明人 Walker Tobias;Wendel Hans-Peter
分类号 C07H21/04;C12N15/113;A61L27/34;A61L31/10;A61K48/00 主分类号 C07H21/04
代理机构 Klarquist Sparkman, LLP 代理人 Klarquist Sparkman, LLP
主权项 1. A composition comprising a nucleic acid molecule for inhibiting the expression of intracellular adhesion molecule 1 (ICAM-1), which comprises at least one of the nucleotide sequences according to SEQ ID No. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14, wherein the composition is a physiological solution for the incubation of organs, and comprises a buffer substance, salts and if necessary, other auxiliaries, actives, additives or preservatives.
地址 Tübingen DE